MOTS-c vs 5-Amino-1MQ
MOTS-c vs 5-Amino-1MQ: mitochondrial peptide vs NNMT inhibitor. Two pathways into metabolic flexibility.
The verdict
Both chase metabolic flexibility from different doors. MOTS-c is a mitochondrial-derived peptide tied to insulin sensitivity and exercise response, basically a 'work with your mitochondria' angle. 5-Amino-1MQ is an NNMT inhibitor that targets the enzyme linked to metabolic stagnation in obesity. The evidence on both is early. If you lean toward the exercise-and-mitochondria story, MOTS-c fits; if the enzyme-inhibition angle interests you, 5-Amino-1MQ does. Treat either as experimental rather than proven.
MOTS-c is a tiny peptide your mitochondria make. It's tied to insulin sensitivity and metabolic flexibility. Used as a metabolic support tool during cuts or when fasting tolerance is low.
5-Amino-1MQ blocks an enzyme called NNMT that gets overactive in obesity and stalls fat loss. Oral capsule. Early human data is promising but limited, best treated as a metabolic adjunct, not a hero.
Which one should you pick?
Pick MOTS-c if users on a cut wanting metabolic support or people with insulin-resistance markers.
Pick 5-Amino-1MQ if users in a stalled cut or plateau-broken stacks late in a diet phase.
Still torn between MOTS-c and 5-Amino-1MQ?
The AI Coach reads both, asks about your goal and experience, and tells you which one actually fits — plus how to dose and stack it. Free.